Silka Michael J, Bar-Cohen Yaniv
Division of Cardiology, Childrens Hospital Los Angeles, Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, California 90027, USA.
Heart Rhythm. 2006 Nov;3(11):1360-6. doi: 10.1016/j.hrthm.2006.02.009. Epub 2006 Feb 28.
The use of pacemakers and implantable cardioverter-defibrillators (ICDs) in infants, children, and patients with congenital heart disease presents unique challenges and considerations. They include uncommon indications for device implantation, innovative approaches to lead implantation and configuration, and age-dependent and disease-specific aspects of device programming. In this review, the current indications for pacemaker and ICD implantation in young patients are discussed, followed by consideration of the approaches to lead and device placement in very small patients and those with complex congenital heart disease, in whom unique problems may be encountered. The limitations of programmability of current pacemakers and ICDs when used in young patients are discussed, followed by an analysis of long-term device follow-up and potential late complications.
在婴儿、儿童以及先天性心脏病患者中使用起搏器和植入式心脏复律除颤器（ICD）存在独特的挑战和需要考虑的因素。这些因素包括设备植入的罕见适应症、导线植入和配置的创新方法，以及与年龄相关和特定疾病的设备编程方面。在本综述中，将讨论年轻患者起搏器和ICD植入的当前适应症，随后考虑在非常小的患者以及患有复杂先天性心脏病的患者中进行导线和设备放置的方法，这些患者可能会遇到独特的问题。还将讨论当前起搏器和ICD在年轻患者中使用时可编程性的局限性，随后分析设备的长期随访情况和潜在的晚期并发症。
